Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hemangiosarcoma × Glutamine × Clear all

Sponsor

Conditions

Peripheral Nervous System Diseases 3 Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 2 Breast Neoplasms 2 Wilms Tumor 1 Vaso-Occlusive Crises 1 Sarcoma 1 Prostatic Neoplasms 1 Pain 1 Neurotoxicity Syndromes 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Extranodal NK-T-Cell 1 Leukemia 1 Kidney Neoplasms 1 Dendritic Cell Sarcoma, Interdigitating 1 Burkitt Lymphoma 1 Anemia, Sickle Cell 1

Interventions

pazopanib 5 Doxorubicin 3 carotuximab 2 Sorafenib 2 Radiotherapy, Conformal 2 Gemcitabine 2 tremelimumab 1 trebananib 1 temsirolimus 1 romidepsin 1 indolepropanol phosphate 1 eribulin 1 durvalumab 1 cixutumumab 1 Watchful Waiting 1 TTI-621 1 Sunitinib 1 Sirolimus 1 Razoxane 1 Paclitaxel 1 Observation 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 HhAntag691 1 Fluorodeoxyglucose F18 1 Docetaxel 1 Dexrazoxane 1 Cyproheptadine 1 Bevacizumab 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡